Approvals/CIMA-AEMPS/AMPICILINA/SULBACTAM REIWA HEALTHCARE 1 G/0,5 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Approved

STANDARD

AMPICILINA/SULBACTAM REIWA HEALTHCARE 1 G/0,5 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG

Reiwa Healthcare S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6b4b7ca95f17e2e4
Drug Cima Aemps Name: AMPICILINA/SULBACTAM REIWA HEALTHCARE 1 G/0,5 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
Register Number: 88957
Holder Company Name: Reiwa Healthcare S.L.
Marketing Company Name: Reiwa Healthcare S.L.
Authorization Date: 2023-07-11
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose: 1.000mg/500 mg
Route Of Administration: VÍA INTRAMUSCULAR, VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Reiwa Healthcare S.L.

AMPICILINA SODICA

1,06 g

SULBACTAM SODICO

0,55 g

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 11, 2023

Approval ID

6b4b7ca95f17e2e4

Type

Standard